Wengui Shi

825 total citations
32 papers, 619 citations indexed

About

Wengui Shi is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, Wengui Shi has authored 32 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Genetics and 9 papers in Pharmacology. Recurrent topics in Wengui Shi's work include Medicinal Plant Pharmacodynamics Research (9 papers), Genetic and Kidney Cyst Diseases (7 papers) and Bone Metabolism and Diseases (7 papers). Wengui Shi is often cited by papers focused on Medicinal Plant Pharmacodynamics Research (9 papers), Genetic and Kidney Cyst Diseases (7 papers) and Bone Metabolism and Diseases (7 papers). Wengui Shi collaborates with scholars based in China, Australia and Ukraine. Wengui Shi's co-authors include Jian Zhou, Cory J. Xian, Yuhai Gao, Keming Chen, Huiping Ma, Jufang Wang, Xiaoni Ma, Qing‐Qing Fang, Xiangyan Jiang and Keming Chen and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

In The Last Decade

Wengui Shi

31 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wengui Shi China 14 350 113 111 96 85 32 619
Stephen C. Jefcoat United States 11 484 1.4× 181 1.6× 177 1.6× 42 0.4× 40 0.5× 11 760
Yoach Rais Israel 12 734 2.1× 147 1.3× 109 1.0× 40 0.4× 18 0.2× 16 954
Elizabeth Pavez Loriè Sweden 10 203 0.6× 49 0.4× 35 0.3× 44 0.5× 18 0.2× 13 389
Jasreen Kular Australia 10 480 1.4× 32 0.3× 254 2.3× 40 0.4× 8 0.1× 12 741
Din‐Lii Lin United States 9 381 1.1× 183 1.6× 212 1.9× 9 0.1× 13 0.2× 13 730
Yun Hyun Huh South Korea 17 350 1.0× 35 0.3× 98 0.9× 74 0.8× 4 0.0× 29 705
Joel A. Yates United States 15 310 0.9× 34 0.3× 112 1.0× 58 0.6× 12 0.1× 28 601
Tsung‐Chuan Ho Taiwan 16 340 1.0× 38 0.3× 39 0.4× 46 0.5× 4 0.0× 28 689
Pablo Astudillo Chile 12 319 0.9× 52 0.5× 111 1.0× 53 0.6× 2 0.0× 20 621

Countries citing papers authored by Wengui Shi

Since Specialization
Citations

This map shows the geographic impact of Wengui Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wengui Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wengui Shi more than expected).

Fields of papers citing papers by Wengui Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wengui Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wengui Shi. The network helps show where Wengui Shi may publish in the future.

Co-authorship network of co-authors of Wengui Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Wengui Shi. A scholar is included among the top collaborators of Wengui Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wengui Shi. Wengui Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Wengui, Zhijian Ma, Xiangyan Jiang, et al.. (2024). Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma. Cancer Research. 84(24). 4156–4172. 1 indexed citations
2.
Li, Zhengyang, et al.. (2024). SHCBP1 Overexpression Aggravates Pancreatitis by Triggering the Loss of Primary Cilia. DNA and Cell Biology. 43(3). 141–151. 1 indexed citations
3.
Li, Jianchun, et al.. (2023). Role of heparanase in sepsis‑related acute kidney injury (Review). Experimental and Therapeutic Medicine. 26(2). 379–379. 6 indexed citations
4.
Shi, Wengui, Jing Yang, Xiangyan Jiang, et al.. (2023). PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric Cancer. Cancer Research. 83(22). 3767–3782. 11 indexed citations
5.
Qin, Long, Junchang Zhang, Huinian Zhou, et al.. (2022). Therapeutic strategies targeting uPAR potentiate anti–PD-1 efficacy in diffuse-type gastric cancer. Science Advances. 8(21). eabn3774–eabn3774. 24 indexed citations
6.
Shi, Wengui, et al.. (2022). Reveal the Mechanisms of Yi-Fei-Jian-Pi-Tang on Covid-19 through Network Pharmacology Approach. Computational Intelligence and Neuroscience. 2022. 1–9. 1 indexed citations
7.
Shi, Wengui, S. Zenz, Zhijian Ma, et al.. (2021). Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer. Nature Communications. 12(1). 2812–2812. 55 indexed citations
8.
Yu, Zeyuan, Xiangyan Jiang, Long Qin, et al.. (2020). A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination. Oncogene. 40(5). 1027–1042. 78 indexed citations
9.
Shi, Wengui, Yanan Zhang, Keming Chen, et al.. (2020). Primary cilia act as microgravity sensors by depolymerizing microtubules to inhibit osteoblastic differentiation and mineralization. Bone. 136. 115346–115346. 25 indexed citations
10.
He, Jinpeng, Xiu Feng, Jufang Wang, et al.. (2018). Icariin prevents bone loss by inhibiting bone resorption and stabilizing bone biological apatite in a hindlimb suspension rodent model. Acta Pharmacologica Sinica. 39(11). 1760–1767. 22 indexed citations
11.
Shi, Wengui, Yuhai Gao, Yuanyuan Wang, et al.. (2017). The flavonol glycoside icariin promotes bone formation in growing rats by activating the cAMP signaling pathway in primary cilia of osteoblasts. Journal of Biological Chemistry. 292(51). 20883–20896. 55 indexed citations
12.
Shi, Wengui, Jinpeng He, Jian Zhou, et al.. (2017). Microgravity induces inhibition of osteoblastic differentiation and mineralization through abrogating primary cilia. Scientific Reports. 7(1). 1866–1866. 51 indexed citations
13.
Zhou, Jian, Yuhai Gao, Wengui Shi, et al.. (2017). [Effect of low frequency low intensity electromagnetic fields on maturation and mineralization of rat skull osteoblasts in vitro].. PubMed. 46(6). 585–592. 1 indexed citations
15.
Ma, Xiaofei, Chengxu Ma, Wengui Shi, et al.. (2016). Primary cilium is required for the stimulating effect of icaritin on osteogenic differentiation and mineralization of osteoblasts in vitro. Journal of Endocrinological Investigation. 40(4). 357–366. 7 indexed citations
16.
Gao, Yuhai, Shaofeng Li, Jian Zhou, et al.. (2016). [Screening the Optimal Time of Sinusoidal Alternating Electromagnetic Field for the Bone Biomechanical Properties of Rat].. PubMed. 33(3). 520–5. 2 indexed citations
18.
Zhou, Jian, Xiaoni Ma, Yuhai Gao, et al.. (2014). Sinusoidal electromagnetic fields promote bone formation and inhibit bone resorption in rat femoral tissuesin vitro. Electromagnetic Biology and Medicine. 35(1). 75–83. 16 indexed citations
19.
Shi, Wengui, et al.. (2014). Icariin promote maturation of osteoblasts in vitro by an estrogen-independent mechanism. China Journal of Chinese Materia Medica. 39(14). 2704–9. 2 indexed citations
20.
Zhou, Jian, Keming Chen, Bao‐Feng Ge, et al.. (2013). Comparison between icariin and genistein in osteogenic activity of marrow stromal cells. China Journal of Chinese Materia Medica. 38(11). 1783–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026